PRESTIGE BRAND HOLDINGS INC
NYSE: PBH (Prestige Consumer Healthcare In)
Last update: 20 hours ago49.92
0.72 (1.46%)
| Previous Close | 49.20 |
| Open | 49.48 |
| Volume | 580,659 |
| Avg. Volume (3M) | 554,245 |
| Market Cap | 2,364,935,936 |
| Price / Earnings (TTM) | 13.98 |
| Price / Earnings (Forward) | 10.55 |
| Price / Sales | 2.08 |
| Price / Book | 1.18 |
| 52 Weeks Range | |
| Earnings Date | 5 Nov 2026 |
| Profit Margin | 18.86% |
| Operating Margin (TTM) | 34.03% |
| Diluted EPS (TTM) | 4.29 |
| Quarterly Revenue Growth (YOY) | 7.10% |
| Quarterly Earnings Growth (YOY) | 1.40% |
| Total Debt/Equity (MRQ) | 56.91% |
| Current Ratio (MRQ) | 4.20 |
| Operating Cash Flow (TTM) | 251.52 M |
| Levered Free Cash Flow (TTM) | 188.69 M |
| Return on Assets (TTM) | 6.50% |
| Return on Equity (TTM) | 12.30% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Drug Manufacturers - Specialty & Generic (US) | Mixed | Mixed |
| Drug Manufacturers - Specialty & Generic (Global) | Mixed | Mixed | |
| Stock | Prestige Consumer Healthcare In | Mixed | Bearish |
AIStockmoo Score
| Analyst Consensus | NA |
| Insider Activity | NA |
| Price Volatility | -1.0 |
| Technical Moving Averages | 2.5 |
| Technical Oscillators | 5.0 |
| Relative Valuation | -5.0 |
| Financial Health | 5.0 |
| AI Insight | NA |
| Weighted Average | 1.63 |
Select this tab to load the latest available analysis.
|
Prestige Consumer Healthcare is one of the largest pure-play over-the-counter healthcare providers. It has a diverse portfolio composed of leading brands in niche consumer health categories. Prestige’s key brands include Clear Eyes (redness relief), Dramamine (motion sickness relief), Monistat (vaginal anti-fungal), and Summer’s Eve (feminine hygiene), and many of its brands enjoy category leadership and recommendations from medical professionals. The firm mainly plays in North America where it generates roughly 85% of its total revenue, and the remaining sales come from Australia, New Zealand, and certain Asian markets. |
|
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
| Investment Style | Small Value |
| % Held by Insiders | 1.23% |
| % Held by Institutions | 108.15% |
No data within this time range.
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2026 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |